Global Coagulation Testing Market to Reach $4.5 Billion by 2030
The global market for Coagulation Testing estimated at US$3.1 Billion in the year 2022, is projected to reach a revised size of US$4.5 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 5.1% CAGR and reach US$3.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 3.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $828.7 Million, While China is Forecast to Grow at 7.4% CAGR
The Coagulation Testing market in the U.S. is estimated at US$828.7 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$990 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.Select Competitors (Total 38 Featured) -
- Abbott Laboratories, Inc.
- Agappe Diagnostics Ltd.
- Alere, Inc.
- F. Hoffmann-La Roche AG
- Helena Laboratories, Inc.
- HemoSonics, LLC
- Horiba, Ltd.
- Medtronic PLC
- Randox Laboratories Ltd.
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Universal Biosensors Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories, Inc.
- Agappe Diagnostics Ltd.
- Alere, Inc.
- F. Hoffmann-La Roche AG
- Helena Laboratories, Inc.
- HemoSonics, LLC
- Horiba, Ltd.
- Medtronic PLC
- Randox Laboratories Ltd.
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific, Inc.
- Universal Biosensors Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 171 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 3.1 Billion |
Forecasted Market Value ( USD | $ 4.5 Billion |
Compound Annual Growth Rate | 4.8% |
Regions Covered | Global |